BRIEF published on 08/24/2026 at 18:51, 3 hours 53 minutes ago Aliko Scientific Updates Financial Position and Business Strategy Cash Flow Business Strategy Convertible Notes Financial Update Oncology Diagnostics
BRIEF published on 08/24/2026 at 18:47, 3 hours 57 minutes ago Aliko Scientific: Financial Status and Outlook Convertible Bonds Financial Situation ALIKO SCIENTIFIC Outlook 2026 Oncological Diagnosis
PRESS RELEASE published on 08/24/2026 at 18:46, 3 hours 58 minutes ago Inside Information: Other news releases ALIKO Scientific provides financial update post FY 2025 results publication, reaffirming business momentum. Details on auditors' reports, financial position, cash flow forecast, and convertible note financing Financial Update Convertible Note Financing Auditors' Reports ALIKO SCIENTIFIC FY 2025 Results
BRIEF published on 07/30/2026 at 21:54, 25 days ago Ikonisys SA announces promising annual results for 2025 Financial Results Growth Ikonisys ALIKO SCIENTIFIC Oncological Diagnosis
BRIEF published on 07/30/2026 at 21:54, 25 days ago Ikonisys SA Reports Increased Revenues and Developments in 2025 Revenue Growth Ikonisys SA Oncology Diagnostics ALIKO SCIENTIFIC Financial Results 2025
PRESS RELEASE published on 07/30/2026 at 21:49, 25 days ago Inside Information / News release on accounts, results Aliko Scientific (Ikonisys SA) reports 52.6% increase in total revenue to €1.64 million and 32.9% improvement in EBITDA for 2025. Developments include US patent for ACTA, launch of Urine24, and agreement with Menarini Diagnostics Financial Results Revenue Increase EBITDA Improvement Oncology Diagnostics ALIKO SCIENTIFIC
BRIEF published on 07/23/2026 at 07:35, 1 month 1 day ago Hospitex International Initiates Urine24 Feasibility Study in Uzbekistan Feasibility Study Cancer Diagnostics Hospitex International Urine24 Uzbek Oncology Institute
BRIEF published on 07/23/2026 at 07:35, 1 month 1 day ago Hospitex International initiates a feasibility study in Uzbekistan for Urine24 Feasibility Study Hospitex International Uzbekistan Urine24 Oncological Diagnoses
PRESS RELEASE published on 07/23/2026 at 07:30, 1 month 1 day ago Inside Information / Other news releases Hospitex International signs agreement with Uzbek Oncology Institute for Urine24 screening project feasibility study, confirming international interest in oncological diagnostic solutions Feasibility Study Hospitex International Urine24 Uzbek Oncology Institute Oncological Diagnostic Solutions
BRIEF published on 05/25/2026 at 19:10, 2 months 30 days ago Aliko Scientific announces a joint venture with BioBrasil for FISH probes Joint Venture Molecular Diagnostics ALIKO SCIENTIFIC BioBrasil FISH Probes
Published on 08/24/2026 at 19:00, 3 hours 45 minutes ago Rio Grande Resources Announces Closing of Over-Subscribed Non-Brokered Private Placement for $2.55 Million
Published on 08/24/2026 at 16:00, 6 hours 45 minutes ago Critical Elements' 10,000-Meter Summer Drill Program at Rose West Continues to Deliver Positive Results
Published on 08/24/2026 at 15:00, 7 hours 45 minutes ago Silver Storm Announces Upsize of Non-Brokered Private Placement to $15.0 Million
Published on 08/24/2026 at 14:30, 8 hours 15 minutes ago AIAI Holdings Commences Discussions with Messier 42 LLC Regarding Acquisition Opportunities
Published on 08/24/2026 at 13:45, 9 hours ago Amarc Announces CAD$20 Million Private Placement Financing
Published on 08/24/2026 at 22:15, 30 minutes ago Amrize Appoints Sam Poletti as Chief Financial Officer
Published on 08/24/2026 at 22:05, 40 minutes ago Nebius Group announces closing of private offering of convertible senior notes, with aggregate gross proceeds of approximately $5.75 billion
Published on 08/24/2026 at 21:29, 1 hour 15 minutes ago Cozy Life Sim Animula Nook Brings a New Beta to gamescom 2026 - Playable Hands-On Demos at the Tencent Games Booth
Published on 08/24/2026 at 19:40, 3 hours 5 minutes ago Gerresheimer AG: Uwe Röhrhoff Steps Down as Interim CEO of Gerresheimer AG
Published on 08/24/2026 at 19:29, 3 hours 16 minutes ago EQS-Adhoc: Gerresheimer AG: Uwe Röhrhoff Steps Down as Interim CEO
Published on 08/24/2026 at 18:00, 4 hours 45 minutes ago Outstanding shares and voting rights statement at 31 July 2026
Published on 08/24/2026 at 17:59, 4 hours 45 minutes ago Saint-Gobain strengthens its positioning in construction chemicals and light construction in Latin America
Published on 08/24/2026 at 17:40, 5 hours 5 minutes ago Eiffage has been awarded in consortium the contract to build two waste-to-energy plants in Limoges and Grenoble in a deal worth close to €162 million (Eiffage share)
Published on 08/24/2026 at 17:35, 5 hours 10 minutes ago Disclosure of transactions in own shares from August 17 to August 21, 2026
